Alerts will be sent to your verified email
Verify EmailSENORES
Balance sheet of Senores Pharmaceutic is strong.
But short term working capital might become an issue for this company.
Yes, The debt of Senores Pharmaceutic is increasing.
Latest debt of Senores Pharmaceutic is ₹222 Crs as of Mar-24.
This is greater than Mar-23 when it was ₹60.59 Crs.
The profit is oscillating.
The profit of Senores Pharmaceutic is ₹23.54 Crs for TTM, ₹31.45 Crs for Mar 2024 and ₹8.43 Crs for Mar 2023.
The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Senores Pharmaceutic latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
Companies resources are allocated to majorly productive assets like Plant & Machinery